US High Purity Solvents Market

ID: MRFR/CnM/16069-HCR
100 Pages
Chitranshi Jaiswal
Last Updated: April 06, 2026
US High Purity Solvents Market Research Report: By Type (Spectrophotometric Solvents, UHPLC and LC/MS Solvents, HPLC Solvents, GC Solvents), By Grade (ACS, Biosolv, Gcsolv, HPLC Grade, Omnisolv, Pestisolv, Purge & Trap, Spectrosolv, Tracegrade, USP, Ultratrace, Unisolv), By Category (Polar Solvent, Non-Polar Solvent), By Application (Liquid Crystals, Lithium Ion Batteries, Electroplating, Resins, Catalysts) and By End User (Pharmaceutical and Biopharmaceutical, Chemical Laboratories, Cosmetics, Food & Beverage, Agriculture, Paints & Coatings, Biotechnology, Electrical & Electronics) - Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Million)
      1. 4.1.1 Spectrophotometric Solvents
      2. 4.1.2 UHPLC and LC/MS Solvents
      3. 4.1.3 HPLC Solvents
      4. 4.1.4 GC Solvents
    2. 4.2 Healthcare, BY Grade (USD Million)
      1. 4.2.1 ACS
      2. 4.2.2 biosolv
      3. 4.2.3 gcsolv
      4. 4.2.4 HPLC grade
      5. 4.2.5 omnisolv
      6. 4.2.6 pestisolv
      7. 4.2.7 purge & trap
      8. 4.2.8 spectrosolv
      9. 4.2.9 tracegrade
      10. 4.2.10 usp
      11. 4.2.11 ultratrace
      12. 4.2.12 unisolv
    3. 4.3 Healthcare, BY Category (USD Million)
      1. 4.3.1 Polar Solvent
      2. 4.3.2 Non-Polar Solvent
    4. 4.4 Healthcare, BY Application (USD Million)
      1. 4.4.1 Liquid Crystals
      2. 4.4.2 Lithium Ion Batteries
      3. 4.4.3 Electroplating
      4. 4.4.4 Resins
      5. 4.4.5 Catalysts
    5. 4.5 Healthcare, BY End User (USD Million)
      1. 4.5.1 Pharmaceutical and Biopharmaceutical
      2. 4.5.2 Chemical Laboratories
      3. 4.5.3 Cosmetics
      4. 4.5.4 Food & Beverage
      5. 4.5.5 Agriculture
      6. 4.5.6 Paints & Coatings
      7. 4.5.7 Biotechnology
      8. 4.5.8 Electrical & Electronics
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Merck KGaA (DE)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Honeywell International Inc. (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 BASF SE (DE)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Thermo Fisher Scientific Inc. (US)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Sigma-Aldrich (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Fisher Scientific (US)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 VWR International (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Avantor, Inc. (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY GRADE
    4. 6.4 US MARKET ANALYSIS BY CATEGORY
    5. 6.5 US MARKET ANALYSIS BY APPLICATION
    6. 6.6 US MARKET ANALYSIS BY END USER
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
    15. 6.15 HEALTHCARE, BY GRADE, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY GRADE, 2024 TO 2035 (USD Million)
    17. 6.17 HEALTHCARE, BY CATEGORY, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY CATEGORY, 2024 TO 2035 (USD Million)
    19. 6.19 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    21. 6.21 HEALTHCARE, BY END USER, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY GRADE, 2025-2035 (USD Million)
      3. 7.2.3 BY CATEGORY, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Healthcare Market Segmentation

Healthcare By Type (USD Million, 2025-2035)

  • Spectrophotometric Solvents
  • UHPLC and LC/MS Solvents
  • HPLC Solvents
  • GC Solvents

Healthcare By Grade (USD Million, 2025-2035)

  • ACS
  • biosolv
  • gcsolv
  • HPLC grade
  • omnisolv
  • pestisolv
  • purge & trap
  • spectrosolv
  • tracegrade
  • usp
  • ultratrace
  • unisolv

Healthcare By Category (USD Million, 2025-2035)

  • Polar Solvent
  • Non-Polar Solvent

Healthcare By Application (USD Million, 2025-2035)

  • Liquid Crystals
  • Lithium Ion Batteries
  • Electroplating
  • Resins
  • Catalysts

Healthcare By End User (USD Million, 2025-2035)

  • Pharmaceutical and Biopharmaceutical
  • Chemical Laboratories
  • Cosmetics
  • Food & Beverage
  • Agriculture
  • Paints & Coatings
  • Biotechnology
  • Electrical & Electronics